1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Diabetes Care Devices Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Diabetes Care Devices Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in diabetes prevalence
- 5.1.2 Growth in demand for monitoring and management devices
5.2 Market Opportunities
- 5.2.1 Expansion in emerging markets
- 5.2.2 Growth in digital health solutions
5.3 Future Trends
- 5.3.1 Increased adoption of glucose monitoring systems
- 5.3.2 Integration with AI for diabetes management
5.4 Impact of Drivers and Restraints
6. North America Diabetes Care Devices Market Regional Analysis
6.1 North America Diabetes Care Devices Market Overview
6.2 North America Diabetes Care Devices Market Revenue 2020-2028 (US$ Million)
6.3 North America Diabetes Care Devices Market Forecast Analysis
7. North America Diabetes Care Devices Market Analysis – by Type
7.1 Glucose Monitoring Devices and Insulin Delivery Devices
- 7.1.1 Overview
- 7.1.2 Glucose Monitoring Devices and Insulin Delivery Devices: North America Diabetes Care Devices Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Diabetes Care Devices Market Analysis – by End User
8.1 Homecare and Hospitals & Clinics
- 8.1.1 Overview
- 8.1.2 Homecare and Hospitals & Clinics : North America Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Diabetes Care Devices Market – North America Analysis
9.1 North America
- 9.1.1 North America Diabetes Care Devices Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.1.1.1 North America Diabetes Care Devices Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.1.2 US: North America Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.2 Canada:
North America Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.2.2 Canada: North America Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.3 Mexico :
North America Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.3.2 Mexico : North America Diabetes Care Devices Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Diabetes Care Devices Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 B. Braun Melsungen AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 BD
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Dexcom, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Eli Lilly and Company.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. Hoffmann-La Roche Ltd.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Insulet Corporation
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medtronic
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Novo Nordisk A/S
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Tandem Diabetes Care Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Terumo Corporation
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Diabetes Care Devices Market
